ADAR1 Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-182,166
Closed -$945K 301
2024
Q3
$945K Buy
+182,166
New +$945K 0.15% 75